Literature DB >> 2474563

Metabolic clearance rate and urinary clearance of purified beta-core.

R E Wehmann1, D L Blithe, M R Flack, B C Nisula.   

Abstract

We injected a highly purified preparation of the beta-core molecule, a fragment of hCG beta excreted in pregnancy urine, into five men and three women to determine its kinetic parameters, MCR, and urinary clearance. The beta-core molecule was distributed in an initial volume [1950 +/- 156 (mean +/- SEM) mL/m2 body surface area] approximately equal to the estimated plasma volume. Its disappearance was multiexponential on a semilogarithmic plot, with a rapid phase t1/2 of 3.5 +/- 0.7 min and a slow phase t1/2 of 22.4 +/- 4.2 min. The transit time (the mean time spent by a molecule of beta-core in transit) was 20.6 +/- 2.1 min. The MCR was 192.0 +/- 8.0 mL/min.m2 body surface area. About 5% of the injected dose of beta-core was excreted into the urine in the first 30 min after injection, and low levels of excretion persisted for up to 7 days. The urinary clearance rate of beta-core was 13.7 +/- 1.4 mL/min.m2, accounting for about 8% of the elimination of beta-core from the plasma. The beta-core immunoreactivity in serum and urine was characterized by gel filtration and three independent RIA systems to show that its properties were indistinguishable from those of the injected beta-core. Serum levels of beta-core in pregnant women were less than 0.2 ng/mL, while the amounts excreted in their urine were as much as 5 mg/day. Based on these clearance parameters of beta-core in normal subjects, less than 0.2% of the beta-core excreted in pregnancy urine is derived by urinary clearance of plasma beta-core. Therefore, more than 99% of the beta-core excreted in pregnancy urine is derived from beta-core in a compartment separate from plasma. In particular, these data indicate that there is relatively little placental secretion of beta-core into plasma and that placental secretion does not account for the vast majority of beta-core in pregnancy urine. These findings are consistent with previous data that point to renal parenchymal degradation of hCG and hCG beta as the major source of urinary beta-core in pregnancy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474563     DOI: 10.1210/jcem-69-3-510

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  The prognostic significance of beta human chorionic gonadotrophin and its metabolites in women with cervical carcinoma.

Authors:  R A Crawford; R K Iles; P G Carter; C J Caldwell; J H Shepherd; T Chard
Journal:  J Clin Pathol       Date:  1998-09       Impact factor: 3.411

2.  HLH beta core fragment immunoreactivity in the urine of ovulating women: a sensitive and specific immunometric assay for its detection.

Authors:  G Kovalevskaya; S Birken; J O'Connor; J Schlatterer; Y Maydelman; R Canfield
Journal:  Endocrine       Date:  1995-12       Impact factor: 3.633

3.  Patterns of LHbetacf among women in health and disease.

Authors:  Steven Birken; Ruth McChesney; Oksana Yershova; John Gaughan; Kim Pettersson; Geoff Rechenberg; Chung H Wu; George Taliadouros
Journal:  Mol Cell Endocrinol       Date:  2006-11-02       Impact factor: 4.102

Review 4.  New discoveries on the biology and detection of human chorionic gonadotropin.

Authors:  Laurence A Cole
Journal:  Reprod Biol Endocrinol       Date:  2009-01-26       Impact factor: 5.211

5.  Immunoextraction-tandem mass spectrometry method for measuring intact human chorionic gonadotropin, free β-subunit, and β-subunit core fragment in urine.

Authors:  Getachew A Woldemariam; Anthony W Butch
Journal:  Clin Chem       Date:  2014-06-04       Impact factor: 8.327

6.  Identification of the LH surge by measuring intact and total immunoreactivity in urine for prediction of ovulation time.

Authors:  And Demir; Matti Hero; Henrik Alfthan; Amro Passioni; Juha S Tapanainen; Ulf-Håkan Stenman
Journal:  Hormones (Athens)       Date:  2022-05-26       Impact factor: 3.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.